Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04551053
Status:
TERMINATED
Last Update Posted:
2024-05-10
First Post:
2020-09-11
Brief Title:
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib LIMBER-304
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Post Polycythemia Vera Myelofibrosis |
| Myelofibrosis |
| Primary Myelofibrosis |
| Post Essential Thrombocythemia Myelofibrosis |